首页> 外文期刊>Hematology. >Comparison of the efficacy of parenteral and oral treatment for nutritional vitamin B12 deficiency in children
【24h】

Comparison of the efficacy of parenteral and oral treatment for nutritional vitamin B12 deficiency in children

机译:肠胃外和口服治疗对儿童营养维生素B12缺乏的疗效的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Although, oral replacement for vitamin B12 deficiency has been proved to be effective in adults, it is mainly treated with parenteral therapy. There are only few studies on oral replacement therapy of vitamin B12 with children. Therefore, we aimed to compare the efficacy of oral treatment with intramuscular vitamin B12 injections in pediatric population. Methods: Children with serum cobalamin concentrations less than 300 pg/mL, were treated either with the parenteral therapy or with oral vitamin B12. The primary and secondary outcomes of the study were the normalization of serum vitamin B12 and hemoglobin at first month, respectively. Results: Post-treatment vitamin B12 values were significantly higher than pre-treatment values (p-value .001). Vitamin B12 increased from 183.5 +/- 47 pg/mL to 482 +/- 318.9 pg/mL in the oral and from 175.5 +/- 42.5 pg/mL to 838 +/- 547 pg/mL in the parenteral treatment arm (p-value .001). Before treatment, 82 children had anemia according to age and gender. After treatment, 14/41 and 8/41 patients still had anemia at the first month of treatment in the parenteral and oral arms, respectively. The number of patients who still have anemia at the end of the 1st month of treatment did not significantly changed in the parenteral and oral treatment groups (p-value = .44). Conclusions: In this study, both oral and parenteral formulations were shown to be effective in normalizing vitamin B12 levels. We suggest that oral formulations may be considered to be safe as a first line treatment for vitamin B12 deficiency in children.
机译:目的:虽然已被证明在成人中有效的口服替代维生素B12缺乏,主要用肠外疗法治疗。只有很少有关于与儿童维生素B12的口腔替代治疗的研究。因此,我们旨在比较口腔治疗与肌内维生素B12在儿科人群中的疗效进行比较。方法:用肠胃外疗法或口服维生素B12处理小于300pg / ml的血清钴胺浓度小于300pg / ml的儿童。该研究的主要和二次结果分别是血清维生素B12和血红蛋白的标准化在第一个月。结果:治疗后维生素B12值显着高于预处理值(p值)。维生素B12从183.5 +/- 47 pg / ml增加到口服中的183.5 +/- 47 pg / ml和175.5 +/- 42.5 pg / ml至838 +/- 547 pg / ml在肠胃外治疗臂(p - value& .001)。治疗前,根据年龄和性别,82名儿童患有贫血。治疗后,14/41和8/41患者分别在肠胃外和口腔武器的第一个月仍有贫血。在治疗的第1个月结束时仍有贫血的患者的数量在肠胃外和口服治疗组中没有显着改变(P值= .44)。结论:在本研究中,显示口腔和肠胃外制剂在标准化维生素B12水平方面有效。我们建议口服配方可以被认为是安全的一种安全,作为儿童维生素B12缺乏的第一线治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号